Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.56 +0.17 (5.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $7.27 | |||
| Open | $3.37 | 52 Week Low | $2.39 | |||
| Day High | $3.57 | P/E | N/A | |||
| Day Low | $3.27 | EPS | $-0.61 | |||
| Volume | 6,051,465 | |||||
